ARS Pharmaceuticals (SPRY) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for ARS Pharmaceuticals (SPRY).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 23M (-19.26%) | 28M (-13.57%) | 33M (+106.74%) | 16M (+97.24%) | 7.97M (-90.79%) | 87M (+4082.61%) | 2.07M (+314.00%) | 500K | - | - | - | 10K (-50.00%) | 20K | - | 190K (-58.70%) | 460K (-30.30%) | 660K (-88.02%) | 5.51M | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 4.34M (+26.16%) | 3.44M (+25.09%) | 2.75M (-31.93%) | 4.04M (+36.95%) | 2.95M (-2.64%) | 3.03M (-31.45%) | 4.42M (-35.94%) | 6.90M (+31.93%) | 5.23M (+53.82%) | 3.40M (+13.33%) | 3.00M (-58.96%) | 7.31M (+11.60%) | 6.55M (+39.07%) | 4.71M (+21.08%) | 3.89M (-10.57%) | 4.35M (-19.74%) | 5.42M | -25.36M | 16M (-11.89%) | 18M (+45.02%) | 12M (+38.46%) | 8.84M (+42.58%) | 6.20M (+20.86%) | 5.13M (+16.33%) | 4.41M |
Selling General And Administrative | 72M (+20.41%) | 60M (-19.79%) | 75M (+37.64%) | 54M (+32.14%) | 41M (+15.81%) | 35M (+84.08%) | 19M (+115.66%) | 8.94M (+12.31%) | 7.96M (-74.96%) | 32M (+112.22%) | 15M (+8222.22%) | 180K (-47.06%) | 340K | -7.12M | 2.93M (+19.11%) | 2.46M (+5.13%) | 2.34M | -15.76M | 7.04M (+4.14%) | 6.76M (+1.65%) | 6.65M (+56.10%) | 4.26M (+123.04%) | 1.91M (+42.54%) | 1.34M (+61.45%) | 830K |
Operating Expenses | 83M (+19.09%) | 70M (-18.84%) | 86M (+35.31%) | 63M (+40.27%) | 45M (+14.65%) | 39M (+65.32%) | 24M (+50.38%) | 16M (+20.09%) | 13M (+28.93%) | 10M (-43.10%) | 18M (-12.76%) | 21M (+10.04%) | 19M (+21.31%) | 15M (+126.39%) | 6.82M (+0.15%) | 6.81M (-12.24%) | 7.76M | -41.12M | 23M (-7.47%) | 25M (+29.75%) | 19M (+44.20%) | 13M (+61.53%) | 8.11M (+25.54%) | 6.46M (+23.28%) | 5.24M |
Depreciation And Amortization | 400K (-63.30%) | 1.09M | - | - | 280K | -30.00K | 100K | - | 10K | -20.00K | 100K | - | 20K | -110.00K | - | - | 210K (-65.00%) | 600K | - | - | 190K (-62.00%) | 500K | - | - | 140K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -60.14M (+45.06%) | -41.46M (-22.05%) | -53.19M (+11.72%) | -47.61M (+28.05%) | -37.18M | 47M | -21.75M (+41.79%) | -15.34M (+16.30%) | -13.19M (+28.93%) | -10.23M (-43.10%) | -17.98M (-12.72%) | -20.60M (+10.10%) | -18.71M (+21.18%) | -15.44M (+132.88%) | -6.63M (+4.57%) | -6.34M (-10.70%) | -7.10M | 47M | -22.68M (-7.47%) | -24.51M (+29.75%) | -18.89M (+44.20%) | -13.10M (+61.53%) | -8.11M (+25.54%) | -6.46M (+23.28%) | -5.24M |
Ebit | -60.14M (+45.06%) | -41.46M (-22.05%) | -53.19M (+11.72%) | -47.61M (+28.05%) | -37.18M | 47M | -21.75M (+41.79%) | -15.34M (+16.30%) | -13.19M (+28.93%) | -10.23M (-43.10%) | -17.98M (-12.72%) | -20.60M (+10.10%) | -18.71M (+21.18%) | -15.44M (+132.88%) | -6.63M (+4.57%) | -6.34M (-10.70%) | -7.10M | 47M | -22.68M (-7.47%) | -24.51M (+29.75%) | -18.89M (+44.20%) | -13.10M (+61.53%) | -8.11M (+25.54%) | -6.46M (+23.28%) | -5.24M |
EBITDA | -59.75M (+32.34%) | -45.15M (-11.73%) | -51.15M (+13.97%) | -44.88M (+21.63%) | -36.90M | 44M | -21.65M (+72.92%) | -12.52M (-5.01%) | -13.18M (-2.23%) | -13.48M (-24.61%) | -17.88M (+2.94%) | -17.37M (-7.06%) | -18.69M (+20.43%) | -15.52M (+135.87%) | -6.58M (+2.49%) | -6.42M (-6.82%) | -6.89M | 47M | -22.65M (-7.55%) | -24.50M (+31.02%) | -18.70M (+48.53%) | -12.59M (+55.05%) | -8.12M (+25.50%) | -6.47M (+26.86%) | -5.10M |
Other Income / Expenses | |||||||||||||||||||||||||
Other Non Operating Income | -470.00K | 8.07M (+295.59%) | 2.04M (-25.27%) | 2.73M (-15.74%) | 3.24M (-71.50%) | 11M (+333.97%) | 2.62M (-7.09%) | 2.82M (-2.76%) | 2.90M (-77.96%) | 13M (+323.15%) | 3.11M (-3.72%) | 3.23M (-13.87%) | 3.75M (+286.60%) | 970K (+1840.00%) | 50K | -80.00K (-46.67%) | -150.00K (-81.01%) | -790.00K | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | -171.38M | - | - | - | 8.29M | - | - | - | -54.36M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Income Tax Expense | - | -80.00K | - | - | - | 290K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -60.62M (+46.71%) | -41.32M (-19.22%) | -51.15M (+13.97%) | -44.88M (+32.23%) | -33.94M | 50M | -19.13M (+52.80%) | -12.52M (+21.67%) | -10.29M (+43.51%) | -7.17M (-51.78%) | -14.87M (-14.39%) | -17.37M (+16.11%) | -14.96M (+3.67%) | -14.43M (+119.30%) | -6.58M (+2.49%) | -6.42M (-11.45%) | -7.25M | 46M | -22.65M (-7.55%) | -24.50M (+29.84%) | -18.87M (+44.27%) | -13.08M (+61.08%) | -8.12M (+25.50%) | -6.47M (+22.54%) | -5.28M |
Net Income | -60.62M (+46.71%) | -41.32M (-19.22%) | -51.15M (+13.97%) | -44.88M (+32.23%) | -33.94M | 50M | -19.13M (+52.80%) | -12.52M (+21.67%) | -10.29M (+43.51%) | -7.17M (-51.78%) | -14.87M (-14.39%) | -17.37M (+16.11%) | -14.96M (+3.67%) | -14.43M (+119.30%) | -6.58M (+2.49%) | -6.42M (-11.45%) | -7.25M | 46M | -22.65M (-7.55%) | -24.50M (+29.84%) | -18.87M (+44.27%) | -13.08M (+61.08%) | -8.12M (+25.50%) | -6.47M (+22.54%) | -5.28M |
Comprehensive Income Net Of Tax | -60.84M (-64.50%) | -171.39M (+235.34%) | -51.11M (+13.58%) | -45.00M (+32.00%) | -34.09M | 8.17M | -18.64M (+48.64%) | -12.54M (+19.89%) | -10.46M (-80.88%) | -54.72M (+268.48%) | -14.85M (-15.72%) | -17.62M (+15.16%) | -15.30M (-55.35%) | -34.27M (+420.82%) | -6.58M (+2.49%) | -6.42M (-11.45%) | -7.25M (-64.18%) | -20.24M (-10.80%) | -22.69M (-7.39%) | -24.50M (+29.84%) | -18.87M (-42.73%) | -32.95M (+305.79%) | -8.12M | - | - |